Seminar - From Lab Bench to GMP: Discovering and Translating Advanced Molecules (BsAb, ADC) Join us for an insightful seminar focused on the discovery and development of complex biologics, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs). This event brings together leading experts from across the biopharmaceutical industry. Through focused talks and Q&A discussion, we’ll explore key technical challenges, practical solutions, and evolving regulatory expectations shaping the future of advanced therapeutics. Register Now Event Details Location: NSG Biolabs, 21 Biopolis Rd, #02-03/05 North Tower, Nucleos 138567, Singapore Date: Thursday 31 July 2025 Time (SGT/GMT+8): Time Topic 16:30-17:00 Registration 17:00-17:20 Overcoming Challenges in the Discovery of Bispecific Antibodies and ADC - Derek Chen, Sr. Director of Antibody Discovery Dept., ProBio 17:20-17:40 Presentation - Raymond Lee, VP of Research, PairX Bio 17:40-18:00 Regulatory Affairs Insights for Complex Drug Modalities - Tina Yu, Sr. Director of RA Dept., ProBio 18:00-18:20 Presentation - Ben Ayers, VP for Antibody-Drug Conjugates, Hummingbird Bioscience 18:20-18:40 Q&A Session 18:40-19:30 Networking with Buffet (Note: we will take questions for all speakers at the end Q&A session) Related service: Bispecific Antibody discovery, ADC discovery, IND-enabling CMC « Previous Page ProBio Announces New Executive Appointments Next Page ProBio Accelerates Chimagen's Global Market Expansion, Paving the Way for Innovative Antibody Therapy » Contact us Phone: 1-877-436-7274 (Toll-Free); 1-732-885-9188 Fax: 1-732-210-0262
Latest WebinarsSeminar - From Lab Bench to GMP: Discovering and Translating Advanced Molecules (BsAb, ADC)Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC InnovationsNavigating Biologics Challenges：Regulatory, Process Development, and Tech Transfer SolutionsPre-clinical DMPK Study and Generation of Toolbox to Facilitate PK/ADA AnalysisFind More Therapeutic Antibody Categories